📰 Vision Risks & Monitoring for Patients on GLP-1 Receptor Agonists

What are GLP-1 Receptor Agonists & Why They Matter
GLP-1 receptor agonists (GLP-1 RAs) are medications used increasingly for:

• Type 2 diabetes to help manage blood sugar
• Weight management / obesity
• Cardiovascular disease risk reduction in people with diabetes or established cardiovascular disease

They have clear benefits: reduced cardiovascular events (heart attack, stroke), better glycemic control, often weight loss. (“Major adverse cardiovascular event” reduction has been demonstrated in several large trials.)

What Recent Evidence Shows: Vision Concerns
While many people tolerate these medications well, recent studies raise some serious concerns for vision, especially retinal and optic nerve health. Below are some findings:

Benefits vs Risks: Putting It in Perspective
The cardiovascular benefits are well established in large randomized controlled trials for those with type 2 diabetes and cardiovascular disease: reduced risk of heart attack, stroke, cardiovascular death. These benefits can be life-saving.
For weight loss / obesity use, benefits also include better metabolic health, less strain on organs, possibly reduced risk of diabetes.
On the flip side, while vision risks seem concerning, they appear to be rare. Absolute risk remains low in most populations. Many of the studies are recently published, observational, not randomized for these specific vision endpoints. Causality not fully proven yet.

What We’re Doing at Eye Was Framed Eyecare
To protect your vision, Dr. Dawn Tuminello and Dr. Nicole Lang are now requesting patients schedule retinal health evaluations every 6 months for patients using GLP-1 receptor agonists. These evaluations include:

• In-clinic exam of retina & optic nerve
• Monitoring for early signs of NAION, macular degeneration, diabetic retinopathy changes
• Home monitoring using the Amsler grid to detect distortions (metamorphopsia), central vision distortion, or sudden changes in vision

We encourage patients to report any vision changes right away: blurring, shadows, sudden loss of vision in one eye, distortion of straight lines etc.

What You Should Know & Do
If you are taking or considering a GLP-1 RA (for diabetes or weight loss), here are some recommendations:

1. Baseline eye exam before starting, if possible.
2. Make sure your retina is evaluated every 6 months while on the medication.
3. Use the Amsler grid at home weekly or as directed. If you see any wavy, missing, distorted areas, report immediately.
4. Maintain good control of blood sugar, blood pressure, cholesterol – these reduce risk for many eye complications.
5. Don’t stop your GLP-1 medication without consulting both your prescriber (endocrinologist or primary care) and your ophthalmologist/optometrist; the benefits for cardiovascular health can be large. But balance with your eye-health status.

Key Takeaways

• GLP-1 RAs are powerful tools in managing diabetes, obesity, and cardiovascular risk.
• Recent evidence suggests possible vision risks: NAION, wet AMD, worsening retinopathy or macular edema. These are rare, but real.
• Regular checkups (every 6 months) and home monitoring are important for early detection.
• Dr. Tuminello and Dr. Lang are now seeing patients specifically for these retinal evaluations.

If you’re using a GLP-1 RA, or thinking about it, schedule an appointment with us to review your retina, check for early signs of trouble, and set up your home monitoring plan. Your vision is too precious to wait.

📞 Call Eye Was Framed Eyecare to book your retinal checkup.  708-460-2020